manchester science partnerships limited Company Information
Company Number
01717239
Next Accounts
Jun 2025
Industry
Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
Shareholders
bruntwood science limited
city of manchester
View AllGroup Structure
View All
Contact
Registered Address
union albert square, manchester, M2 6LW
Website
http://mspl.co.ukmanchester science partnerships limited Estimated Valuation
Pomanda estimates the enterprise value of MANCHESTER SCIENCE PARTNERSHIPS LIMITED at £24.1m based on a Turnover of £7.9m and 3.05x industry multiple (adjusted for size and gross margin).
manchester science partnerships limited Estimated Valuation
Pomanda estimates the enterprise value of MANCHESTER SCIENCE PARTNERSHIPS LIMITED at £5.6m based on an EBITDA of £924k and a 6.02x industry multiple (adjusted for size and gross margin).
manchester science partnerships limited Estimated Valuation
Pomanda estimates the enterprise value of MANCHESTER SCIENCE PARTNERSHIPS LIMITED at £87.3m based on Net Assets of £51m and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Manchester Science Partnerships Limited Overview
Manchester Science Partnerships Limited is a live company located in manchester, M2 6LW with a Companies House number of 01717239. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in April 1983, it's largest shareholder is bruntwood science limited with a 66.9% stake. Manchester Science Partnerships Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.9m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Manchester Science Partnerships Limited Health Check
Pomanda's financial health check has awarded Manchester Science Partnerships Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
4 Weak
Size
annual sales of £7.9m, make it larger than the average company (£849.8k)
£7.9m - Manchester Science Partnerships Limited
£849.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a similar rate (2.8%)
3% - Manchester Science Partnerships Limited
2.8% - Industry AVG
Production
with a gross margin of 34.9%, this company has a higher cost of product (72.3%)
34.9% - Manchester Science Partnerships Limited
72.3% - Industry AVG
Profitability
an operating margin of 8.8% make it less profitable than the average company (27.3%)
8.8% - Manchester Science Partnerships Limited
27.3% - Industry AVG
Employees
with 44 employees, this is above the industry average (4)
- Manchester Science Partnerships Limited
4 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Manchester Science Partnerships Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £179.4k, this is equally as efficient (£181.3k)
- Manchester Science Partnerships Limited
£181.3k - Industry AVG
Debtor Days
it gets paid by customers after 20 days, this is earlier than average (33 days)
20 days - Manchester Science Partnerships Limited
33 days - Industry AVG
Creditor Days
its suppliers are paid after 26 days, this is quicker than average (34 days)
26 days - Manchester Science Partnerships Limited
34 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Manchester Science Partnerships Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (12 weeks)
1 weeks - Manchester Science Partnerships Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 63.9%, this is a similar level of debt than the average (68.1%)
63.9% - Manchester Science Partnerships Limited
68.1% - Industry AVG
MANCHESTER SCIENCE PARTNERSHIPS LIMITED financials
Manchester Science Partnerships Limited's latest turnover from September 2023 is £7.9 million and the company has net assets of £51 million. According to their latest financial statements, we estimate that Manchester Science Partnerships Limited has 44 employees and maintains cash reserves of £1.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7,894,000 | 7,427,000 | 8,428,000 | 7,330,000 | 6,681,000 | 6,881,000 | 6,376,000 | 5,783,000 | 5,959,000 | 5,381,000 | 4,693,000 | 2,831,000 | 3,722,324 | 3,167,640 | 3,058,992 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 5,139,000 | 4,076,000 | 4,549,000 | 4,446,000 | 3,964,000 | 4,107,000 | 2,895,000 | 2,699,000 | 2,885,000 | 2,678,000 | 2,532,000 | 1,232,000 | 1,279,321 | 1,456,431 | 1,402,571 |
Gross Profit | 2,755,000 | 3,351,000 | 3,879,000 | 2,884,000 | 2,717,000 | 2,774,000 | 3,481,000 | 3,084,000 | 3,074,000 | 2,703,000 | 2,161,000 | 1,599,000 | 2,443,003 | 1,711,209 | 1,656,421 |
Admin Expenses | 2,064,000 | 2,342,000 | 2,235,000 | 1,617,000 | 1,679,000 | 2,357,000 | 2,435,000 | 2,376,000 | 1,452,000 | 1,824,429 | 930,778 | 1,048,219 | |||
Operating Profit | 691,000 | 1,009,000 | 1,644,000 | 1,267,000 | 1,038,000 | 417,000 | 1,046,000 | 708,000 | 1,622,000 | 618,574 | 780,431 | 608,202 | |||
Interest Payable | 2,751,000 | 1,305,000 | 990,000 | 997,000 | 1,623,000 | 1,345,000 | 1,129,000 | 1,013,000 | 834,000 | 698,000 | 454,000 | 280,000 | 356,733 | 311,679 | 342,612 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 2,000 | 0 | 0 | 4,000 | 5,000 | 4,000 | 5,679 | 1,882 | 1,068 |
Pre-Tax Profit | -18,806,000 | 18,927,000 | 2,275,000 | 3,189,000 | 911,000 | 7,387,000 | 2,651,000 | 1,057,000 | 5,147,000 | 996,000 | 713,000 | 176,000 | 267,520 | 720,634 | 275,257 |
Tax | 4,365,000 | -4,823,000 | -2,047,000 | -1,067,000 | -232,000 | -1,394,000 | -317,000 | 392,000 | -1,004,000 | -55,000 | 4,000 | -4,000 | 26,911 | -200,279 | -78,257 |
Profit After Tax | -14,441,000 | 14,104,000 | 228,000 | 2,122,000 | 679,000 | 5,993,000 | 2,334,000 | 1,449,000 | 4,143,000 | 941,000 | 717,000 | 172,000 | 294,431 | 520,355 | 197,000 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -14,441,000 | 14,104,000 | 228,000 | 2,122,000 | 679,000 | 5,993,000 | 2,334,000 | 1,449,000 | 4,143,000 | 941,000 | 717,000 | 172,000 | 294,431 | 520,355 | 197,000 |
Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 380,000 | 292,000 | 447,000 | 1,046,000 | 1,462,477 | 1,440,985 | |
Number Of Employees | 13 | 15 | 21 | 44 | 48 | 49 | |||||||||
EBITDA* | 924,000 | 1,231,000 | 2,031,000 | 1,599,000 | 1,285,000 | 535,000 | 1,087,000 | 761,000 | 1,674,000 | 672,823 | 847,172 | 701,633 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 103,360,000 | 116,391,000 | 91,015,000 | 77,844,000 | 73,848,000 | 71,854,000 | 60,591,000 | 52,325,000 | 38,987,000 | 31,790,000 | 23,083,000 | 21,504,000 | 20,724,144 | 92,668 | 19,509,029 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 31,143,000 | 27,912,000 | 26,081,000 | 25,259,000 | 6,904,000 | 6,904,000 | 6,903,000 | 6,903,000 | 6,903,000 | 6,429,000 | 2,500,000 | 842,000 | 701 | 20,382,799 | 701 |
Debtors (Due After 1 year) | 3,010,000 | 3,121,000 | 410,000 | 1,802,000 | 1,038,000 | 837,000 | 75,000 | 0 | 0 | 13,495,000 | 7,220,000 | 3,540,000 | 57,432 | 646,822 | 627,415 |
Total Fixed Assets | 137,513,000 | 147,424,000 | 117,506,000 | 104,905,000 | 81,790,000 | 79,595,000 | 67,569,000 | 59,228,000 | 45,890,000 | 51,714,000 | 32,803,000 | 25,886,000 | 20,782,277 | 21,122,289 | 20,137,145 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 446,000 | 596,000 | 1,103,000 | 838,000 | 1,266,000 | 1,024,000 | 590,000 | 365,000 | 967,000 | 445,000 | 409,000 | 218,000 | 130,773 | 213,917 | 282,058 |
Group Debtors | 61,000 | 57,000 | 0 | 3,000 | 16,482,000 | 20,190,000 | 20,139,000 | 23,527,000 | 24,925,000 | 0 | 46,000 | 113,000 | 197,064 | 352,550 | 186,045 |
Misc Debtors | 2,272,000 | 1,462,000 | 1,365,000 | 86,000 | 1,055,000 | 957,000 | 885,000 | 479,000 | 804,000 | 657,000 | 217,000 | 314,000 | 183,671 | 142,084 | 119,291 |
Cash | 1,167,000 | 129,000 | 806,000 | 472,000 | 1,305,000 | 2,325,000 | 2,348,000 | 1,960,000 | 1,604,000 | 544,000 | 2,168,000 | 723,000 | 1,764,692 | 1,458,777 | 1,585,250 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 3,946,000 | 2,244,000 | 3,274,000 | 1,399,000 | 20,108,000 | 24,496,000 | 23,962,000 | 26,331,000 | 28,300,000 | 1,646,000 | 2,840,000 | 1,368,000 | 2,276,200 | 2,167,328 | 2,172,644 |
total assets | 141,459,000 | 149,668,000 | 120,780,000 | 106,304,000 | 101,898,000 | 104,091,000 | 91,531,000 | 85,559,000 | 74,190,000 | 53,360,000 | 35,643,000 | 27,254,000 | 23,058,477 | 23,289,617 | 22,309,789 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,973,000 | 0 | 0 | 0 | 6,000,000 | 6,000,000 |
Trade Creditors | 376,000 | 331,000 | 459,000 | 54,000 | 402,000 | 761,000 | 818,000 | 222,000 | 219,000 | 318,000 | 489,000 | 31,000 | 38,165 | 74,858 | 131,472 |
Group/Directors Accounts | 18,589,000 | 10,988,000 | 12,563,000 | 10,325,000 | 8,901,000 | 1,575,000 | 2,288,000 | 2,142,000 | 2,801,000 | 2,897,000 | 1,613,000 | 43,000 | 21,165 | 154,040 | 160,507 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,167,000 | 0 | 0 | 0 | 0 | 0 | 0 | 76,000 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 12,171,000 | 9,294,000 | 12,009,000 | 5,594,000 | 5,714,000 | 7,341,000 | 3,629,000 | 2,838,000 | 2,196,000 | 1,906,000 | 2,196,000 | 1,176,000 | 1,146,298 | 1,117,356 | 1,129,021 |
total current liabilities | 31,136,000 | 20,613,000 | 25,031,000 | 15,973,000 | 15,017,000 | 9,677,000 | 6,735,000 | 10,369,000 | 5,216,000 | 17,094,000 | 4,298,000 | 1,250,000 | 1,205,628 | 7,346,254 | 7,497,000 |
loans | 51,605,000 | 51,531,000 | 36,875,000 | 34,009,000 | 33,748,000 | 42,173,000 | 39,983,000 | 32,813,000 | 27,880,000 | 0 | 12,964,000 | 6,000,000 | 6,000,000 | 0 | 540,000 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 277,000 | 0 | 0 | 0 | 23,000 | 151,000 | 91,000 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 7,672,000 | 12,037,000 | 7,214,000 | 5,167,000 | 4,100,000 | 3,887,000 | 2,429,000 | 2,199,000 | 2,425,000 | 686,000 | 633,000 | 713,000 | 770,287 | 853,966 | 791,302 |
total long term liabilities | 59,277,000 | 63,568,000 | 44,366,000 | 39,176,000 | 37,848,000 | 46,060,000 | 42,435,000 | 35,163,000 | 30,396,000 | 686,000 | 13,597,000 | 6,713,000 | 6,770,287 | 853,966 | 1,331,302 |
total liabilities | 90,413,000 | 84,181,000 | 69,397,000 | 55,149,000 | 52,865,000 | 55,737,000 | 49,170,000 | 45,532,000 | 35,612,000 | 17,780,000 | 17,895,000 | 7,963,000 | 7,975,915 | 8,200,220 | 8,828,302 |
net assets | 51,046,000 | 65,487,000 | 51,383,000 | 51,155,000 | 49,033,000 | 48,354,000 | 42,361,000 | 40,027,000 | 38,578,000 | 35,580,000 | 17,748,000 | 19,291,000 | 15,082,562 | 15,089,397 | 13,481,487 |
total shareholders funds | 51,046,000 | 65,487,000 | 51,383,000 | 51,155,000 | 49,033,000 | 48,354,000 | 42,361,000 | 40,027,000 | 38,578,000 | 35,580,000 | 17,748,000 | 19,291,000 | 15,082,562 | 15,089,397 | 13,481,487 |
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 691,000 | 1,009,000 | 1,644,000 | 1,267,000 | 1,038,000 | 417,000 | 1,046,000 | 708,000 | 1,622,000 | 618,574 | 780,431 | 608,202 | |||
Depreciation | 233,000 | 222,000 | 387,000 | 332,000 | 247,000 | 118,000 | 41,000 | 53,000 | 52,000 | 59,000 | 51,000 | 35,000 | 54,249 | 66,741 | 93,431 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 4,365,000 | -4,823,000 | -2,047,000 | -1,067,000 | -232,000 | -1,394,000 | -317,000 | 392,000 | -1,004,000 | -55,000 | 4,000 | -4,000 | 26,911 | -200,279 | -78,257 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 553,000 | 2,358,000 | 149,000 | -17,112,000 | -3,167,000 | 1,319,000 | -2,682,000 | -2,325,000 | 12,099,000 | 6,705,000 | 3,707,000 | 3,616,060 | -786,433 | 140,564 | 1,214,809 |
Creditors | 45,000 | -128,000 | 405,000 | -348,000 | -359,000 | -57,000 | 596,000 | 3,000 | -99,000 | -171,000 | 458,000 | -7,165 | -36,693 | -56,614 | 131,472 |
Accruals and Deferred Income | 2,877,000 | -2,715,000 | 6,415,000 | -120,000 | -1,627,000 | 3,712,000 | 791,000 | 642,000 | 290,000 | -290,000 | 1,020,000 | 29,702 | 28,942 | -11,665 | 1,129,021 |
Deferred Taxes & Provisions | -4,365,000 | 4,823,000 | 2,047,000 | 1,067,000 | 213,000 | 1,458,000 | 230,000 | -226,000 | 1,739,000 | 53,000 | -80,000 | -57,287 | -83,679 | 62,664 | 791,302 |
Cash flow from operations | 3,293,000 | -3,970,000 | 8,702,000 | 18,243,000 | 2,447,000 | 2,935,000 | 5,069,000 | 3,897,000 | -9,499,000 | 1,394,737 | 500,714 | 1,460,362 | |||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 3,231,000 | 1,831,000 | 822,000 | 18,355,000 | 0 | 1,000 | 0 | 0 | 474,000 | 3,929,000 | 1,658,000 | 841,299 | -20,382,098 | 20,382,098 | 701 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11,973,000 | 11,973,000 | 0 | 0 | -6,000,000 | 0 | 6,000,000 |
Group/Directors Accounts | 7,601,000 | -1,575,000 | 2,238,000 | 1,424,000 | 7,326,000 | -713,000 | 146,000 | -659,000 | -96,000 | 1,284,000 | 1,570,000 | 21,835 | -132,875 | -6,467 | 160,507 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | -5,167,000 | 5,167,000 | 0 | 0 | 0 | 0 | 0 | -76,000 | 76,000 |
Long term loans | 74,000 | 14,656,000 | 2,866,000 | 261,000 | -8,425,000 | 2,190,000 | 7,170,000 | 4,933,000 | 27,880,000 | -12,964,000 | 6,964,000 | 0 | 6,000,000 | -540,000 | 540,000 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | -277,000 | 277,000 | 0 | 0 | -23,000 | -128,000 | 60,000 | 91,000 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | -2,751,000 | -1,305,000 | -990,000 | -997,000 | -1,623,000 | -1,345,000 | -1,127,000 | -1,013,000 | -834,000 | -694,000 | -449,000 | -276,000 | -351,054 | -309,797 | -341,544 |
cash flow from financing | 4,924,000 | 11,499,000 | 4,391,000 | 688,000 | -2,722,000 | 109,000 | 894,000 | 8,488,000 | 13,923,000 | 16,490,000 | 5,825,000 | 3,782,273 | -785,195 | 155,291 | 19,719,450 |
cash and cash equivalents | |||||||||||||||
cash | 1,038,000 | -677,000 | 334,000 | -833,000 | -1,020,000 | -23,000 | 388,000 | 356,000 | 1,060,000 | -1,624,000 | 1,445,000 | -1,041,692 | 305,915 | -126,473 | 1,585,250 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 1,038,000 | -677,000 | 334,000 | -833,000 | -1,020,000 | -23,000 | 388,000 | 356,000 | 1,060,000 | -1,624,000 | 1,445,000 | -1,041,692 | 305,915 | -126,473 | 1,585,250 |
manchester science partnerships limited Credit Report and Business Information
Manchester Science Partnerships Limited Competitor Analysis
Perform a competitor analysis for manchester science partnerships limited by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other mid companies, companies in M 2 area or any other competitors across 12 key performance metrics.
manchester science partnerships limited Ownership
MANCHESTER SCIENCE PARTNERSHIPS LIMITED group structure
Manchester Science Partnerships Limited has 8 subsidiary companies.
Ultimate parent company
2 parents
MANCHESTER SCIENCE PARTNERSHIPS LIMITED
01717239
8 subsidiaries
manchester science partnerships limited directors
Manchester Science Partnerships Limited currently has 9 directors. The longest serving directors include Mr Christopher Oglesby (Apr 2012) and Professor Luke Georghiou (Sep 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Christopher Oglesby | England | 57 years | Apr 2012 | - | Director |
Professor Luke Georghiou | United Kingdom | 69 years | Sep 2014 | - | Director |
Professor Malcolm Press | England | 66 years | Jun 2015 | - | Director |
Mr Sean Davies | United Kingdom | 48 years | Jan 2018 | - | Director |
Mrs Claire Robinson | England | 54 years | Nov 2018 | - | Director |
Ms Patricia Bartoli | United Kingdom | 59 years | May 2020 | - | Director |
Mr Nicholas Brook | England | 60 years | Sep 2022 | - | Director |
Mr Bradley Topps | United Kingdom | 36 years | Dec 2023 | - | Director |
Mr Kevin Crotty | United Kingdom | 48 years | Dec 2023 | - | Director |
P&L
September 2023turnover
7.9m
+6%
operating profit
691k
-32%
gross margin
34.9%
-22.65%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
51m
-0.22%
total assets
141.5m
-0.05%
cash
1.2m
+8.05%
net assets
Total assets minus all liabilities
manchester science partnerships limited company details
company number
01717239
Type
Private limited with Share Capital
industry
68209 - Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
incorporation date
April 1983
age
42
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
September 2023
previous names
manchester science parks limited (September 2014)
manchester science park limited (September 2009)
accountant
-
auditor
DELOITTE LLP
address
union albert square, manchester, M2 6LW
Bank
LLOYDS TSB BANK PLC
Legal Advisor
ADDLESHAW GODDARD LLP
manchester science partnerships limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 23 charges/mortgages relating to manchester science partnerships limited. Currently there are 2 open charges and 21 have been satisfied in the past.
manchester science partnerships limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MANCHESTER SCIENCE PARTNERSHIPS LIMITED. This can take several minutes, an email will notify you when this has completed.
manchester science partnerships limited Companies House Filings - See Documents
date | description | view/download |
---|